CD79A and COVID-19: The right shifting amide I peak in COVID.POSFU.POS, compared to both COVID.NEG and COVID.POSFU.NEG, is in agreement with residual misfolded amyloid protein fibrils and elevated IgA in COVID-19 patient saliva (Figure S5) [9,26,27].